Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agents.

× No keyword cloud information.

14 in total

1. Melanin synthesis and the action of L-dopa and 3,4-dihydroxybenzylamine in human melanoma cells.

Authors: E P Kable; P G Parsons
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

2. 3,4-Dihydroxy-benzohydroxamic acid (Didox) suppresses pro-inflammatory profiles and oxidative stress in TLR4-activated RAW264.7 murine macrophages.

Authors: Thabe M Matsebatlela; Amy L Anderson; Vincent S Gallicchio; Howard Elford; Charles D Rice
Journal: Chem Biol Interact Date: 2015-04-02 Impact factor: 5.192

3. Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IL-33-induced cytokine production in primary mouse mast cells.

Authors: Heather L Caslin; Jamie Josephine Avila McLeod; Andrew J Spence; Amina Abdul Qayum; Elizabeth Motunrayo Kolawole; Marcela T Taruselli; Anuya Paranjape; Howard L Elford; John J Ryan
Journal: Cell Immunol Date: 2017-07-11 Impact factor: 4.868

4. A degradation product of fenitrothion, 3-methyl-4-nitrophenol, is an inhibitor of mammalian ribonucleotide reductase.

Authors: J A Wright; M W Hermonat; R G Hards
Journal: Bull Environ Contam Toxicol Date: 1982-04 Impact factor: 2.151

5. Antimalarial activities of polyhydroxyphenyl and hydroxamic acid derivatives.

Authors: K P Holland; H L Elford; V Bracchi; C G Annis; S M Schuster; D Chakrabarti
Journal: Antimicrob Agents Chemother Date: 1998-09 Impact factor: 5.191

Review 6. Nucleotide metabolism, oncogene-induced senescence and cancer.

Authors: Katherine M Aird; Rugang Zhang
Journal: Cancer Lett Date: 2014-01-29 Impact factor: 8.679

Review 7. Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present.

Authors: Sarah E Huff; Jordan M Winter; Chris G Dealwis
Journal: Biomolecules Date: 2022-06-10

8. Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase.

Authors: T Szekeres; K Gharehbaghi; M Fritzer; M Woody; A Srivastava; B van't Riet; H N Jayaram; H L Elford
Journal: Cancer Chemother Pharmacol Date: 1994 Impact factor: 3.333

9. Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IgE-mediated mast cell activation through attenuation of NFκB and AP-1 transcription.

Authors: Jamie Josephine Avila McLeod; Heather L Caslin; Andrew J Spence; Elizabeth M Kolawole; Amina Abdul Qayum; Anuya Paranjape; Marcela Taruselli; Tamara T Haque; Kasalina N Kiwanuka; Howard L Elford; John J Ryan
Journal: Cell Immunol Date: 2017-09-21 Impact factor: 4.868

10. A phase 1 and pharmacokinetic study of didox: a ribonucleotide reductase inhibitor.

Authors: D Veale; J Carmichael; B M Cantwell; H L Elford; R Blackie; D J Kerr; S B Kaye; A L Harris
Journal: Br J Cancer Date: 1988-07 Impact factor: 7.640